Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis

Coronavirus Disease 2019 (COVID-19) can present with different grades of severity from mild to critical. Evaluation of biomarkers predicting severity is crucial to identify patients at high risk of disease progression and poor prognosis. Serum Amyloid A (SAA) is an acute-phase protein mainly produce...

Descripción completa

Detalles Bibliográficos
Autores principales: Pieri, Massimo, Ciotti, Marco, Nuccetelli, Marzia, Perrone, Marco Alfonso, Caliò, Maria Teresa, Lia, Maria Stella, Minieri, Marilena, Bernardini, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923863/
https://www.ncbi.nlm.nih.gov/pubmed/33735714
http://dx.doi.org/10.1016/j.intimp.2021.107512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923863/
https://www.ncbi.nlm.nih.gov/pubmed/33735714
http://dx.doi.org/10.1016/j.intimp.2021.107512

Ejemplares similares